SIG Corner Editor: Hana Abouzeid

Chair: John Thygesen
Co-chair: Gus Gazzard


The goal of this SIG is to further the promotion of knowledge about the diagnosis, treatment and management of angle closure disease in all its forms.

1) Update on Angle Closure SIG activities

DAP: Danish Angle Closure Prevention Trial The SIG meeting 2022 at EGS meeting in Athens agreed that for the next year the main research focus would be to support a proposed trial of LPI for PACS in Europeans. This was presented by Niklas Telinius with several ideas as to how to make such an RCT feasible and included novel sample size modelling and a proposal to conduct patient focus groups to inform trial design.

2) Last year’s choices of relevant papers to the Angle Closure

Updates on Genes and Genetic Mechanisms Implicated in Primary Angle-Closure Glaucoma Altaf A Kondkar, Appl Clin Genet. 2021; 14: 89–112. Published online 2021 Mar 9. doi: 10.2147/TACG.S274884 PMCID: PMC7955727 PMID: 33727852 PMCID: PMC7847989 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955727/

Prevalence of Primary Angle Closure Glaucoma in the Last 20 Years: A Meta-Analysis and Systematic Review Nan Zhang, Jiaxing Wang, Biyue Chen, Ying Li, Bing Jiang Front Med (Lausanne): 2021 Jan 18;7:624179. eCollection 2020. PMID: 33537335 PMCID: PMC7847989 DOI: 10.3389/fmed.2020.624179 https://pubmed.ncbi.nlm.nih.gov/33537335/

The search for EGS goal of “Paving the Way to Better Glaucoma Care” continues together with Outcome and other EGS Committees as well as SIGs, i.e. how to promote the best possible well-being and minimal glaucoma-induced visual disability in individuals with glaucoma within affordable healthcare systems.

The views expressed are those of the author(s) and are not necessarily those of the EGS.